ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 41 filers reported holding ESSA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510 | -56.1% | 165 | -61.6% | 0.00% | – |
| Q2 2023 | $1,162 | -88.0% | 430 | -86.8% | 0.00% | – |
| Q1 2023 | $9,664 | -41.2% | 3,254 | -50.1% | 0.00% | – |
| Q4 2022 | $16,435 | -81.7% | 6,522 | -77.2% | 0.00% | – |
| Q2 2022 | $90,000 | -53.6% | 28,551 | -9.2% | 0.00% | – |
| Q1 2022 | $194,000 | -56.1% | 31,442 | +1.1% | 0.00% | – |
| Q4 2021 | $442,000 | +271.4% | 31,113 | +109.0% | 0.00% | – |
| Q3 2021 | $119,000 | -92.8% | 14,886 | -74.4% | 0.00% | -100.0% |
| Q2 2021 | $1,658,000 | +6532.0% | 58,040 | +6586.6% | 0.00% | – |
| Q1 2021 | $25,000 | +400.0% | 868 | +114.9% | 0.00% | – |
| Q4 2020 | $5,000 | -73.7% | 404 | -85.3% | 0.00% | – |
| Q3 2020 | $19,000 | +171.4% | 2,751 | +69.3% | 0.00% | – |
| Q1 2020 | $7,000 | +75.0% | 1,625 | +128.2% | 0.00% | – |
| Q4 2019 | $4,000 | – | 712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |